US Stock MarketDetailed Quotes
ARGX argenx SE
- 586.300
- +34.590+6.27%
Close Oct 31 16:00 ET
- 587.060
- +0.760+0.13%
Post 16:06 ET
35.06BMarket Cap-751666P/E (TTM)
589.600High566.570Low756.78KVolume589.600Open551.710Pre Close440.53MTurnover1.27%Turnover RatioLossP/E (Static)59.80MShares589.60052wk High8.23P/B34.82BFloat Cap327.72552wk Low--Dividend TTM59.40MShs Float589.600Historical High--Div YieldTTM4.17%Amplitude17.330Historical Low582.109Avg Price1Lot Size
About argenx SE Company
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Company Profile
SymbolARGX
Company Nameargenx SE
Listing DateMay 18, 2017
Issue Price17.00
Founded2008
CEOMr. Tim Van Hauwermeiren, M. Sc.
MarketNASDAQ
Employees1148
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLaarderhoogtweg 25
CityAmsterdam
ProvinceNoord-Holland
CountryNetherlands (the)
Zip Code1101 EB
Phone31-76-303-04-88
Websitehttp://www.argen-x.com
Company Executives
- Name
- Position
- Salary
- Tim Van Hauwermeiren, M. Sc.
- Executive Director and Chief Executive Officer
- 17.45M
- Karen Massey
- Chief Operating Officer
- 7.32M
- Dr. Peter Ulrichts
- Chief Scientific Officer
- --
- Dr. Luc Truyen, M.D.,PhD
- Chief Medical Officer
- --
- Karl Gubitz
- Chief Financial Officer
- 4.76M
- Arjen Lemmen
- Vice President, Corporate Development and Strategy
- --
- Peter K.M. Verhaeghe
- Non-Executive Chairman of the Board
- 660.33K
- Camilla Sylvest
- Independent Director
- 365.24K
- Anthony A. Rosenberg
- Independent Director
- 476.82K
- James M. Daly
- Independent Director
- 482.23K
- Dr. Ana Cespedes, PhD
- Independent Director
- 261.39K
- Steven E. Krognes
- Independent Director
- 635.65K
- Dr. Pamela M. Klein, M.D.
- Independent Director
- 471.41K
- Dr. J. Donald deBethizy, PhD
- Independent Director
- 482.23K
- Malini Moorthy
- General Counsel
- --
- Andria Wilk
- Global Head, Quality
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data